Comparative evaluation of Transcutaneous Electrical Nerve Stimulation (TENS) and astaxanthin in Myofascial Pain Dysfunction Syndrome (MPDS)

Comparative evaluation of efficacy of Transcutaneous Electrical Nerve Stimulation (TENS), Transcutaneous Electrical Nerve Stimulation with Muscle relaxant, Transcutaneous Electrical Nerve Stimulation with Astaxanthin and Astaxanthin alone in the management of Myofascial Pain Dysfunction Syndrome (MPDS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052453

Enrollment

120

Registered

2023-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Transcutaneous Electrical Nerve Stimulation (TENS): physiotheraputic modality for 10 sessions, 3 sessions per week for 10 minutes Control Intervention1: Astaxanthin: antioxidant drug 8

Eligibility

Inclusion criteria

Inclusion criteria: using Laskinâ??s criteria and DC/TMD Axis I and II criteria

Exclusion criteria

Exclusion criteria: â?¢ Patients Under management â?¢ Patients with congenital anomalies of TMJ â?¢ History of craniofacial trauma/fracture â?¢ Any other diseases causing TMJ pain â?¢ Congenital or degenerative changes of the spine â?¢ Patients with mental disorders/stress â?¢ Patients with pacemaker â?¢ Pregnant females â?¢ Patients with allergic to gel

Design outcomes

Primary

Measure	Time frame
relief from muscle pain and tenderness increase in mouth openingTimepoint: from day one (Base line up to 2 months)	—

Secondary

Measure	Time frame
to assess quality of lifeTimepoint: baseline, 1 month and 2 months	—

Countries

India

Contacts

Public ContactDr Smriti Jagdhari Golhar

Sharad Pawar Dental College And Hospital

artipanch@gmail.com9822220023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026